Creative Arts Therapy May Help Pediatric Cancer Patients Cope With Anxiety
Creative arts therapy can ease procedural anxiety in pediatric patients undergoing their first year of cancer treatment, a study suggests.
Pediatric Cancer News
PEDIATRIC CANCER ADVISOR
Pediatric Cancer News
AYAs With Hematologic Malignancies Have Higher Risk of Early Death
The risk of early death in AYAs with cancer depends on the type of malignancy they have as well as multiple demographic factors, a study suggests.
Geography and Race/Ethnicity Impact Access to Pediatric Cancer Care
New research has revealed disparities in access to cancer care among children, adolescents, and young adults in the United States.
Most Pediatric Oncologists Don’t Discuss Prognosis When Diagnosing Patients, Study Suggests
Pediatric oncologists often choose not to provide prognostic information when discussing a new cancer diagnosis, a new study suggests.
Posoleucel Deemed Effective Against Viral Infections in Allogeneic HSCT Recipients
Posoleucel appears safe and effective for treating refractory viral infections occurring after allogeneic hematopoietic stem cell transplant.
Survival Rates High for Children, Teens With Melanoma
Recurrence-free survival and overall survival rates were similar in children and adolescents with melanoma.
Hispanic Patients May Have Increased Risk of CRS After CAR T-Cell Therapy
Researchers sought to determine whether race, ethnicity, or BMI would have an impact on CAR T-cell therapy outcomes in patients with B-ALL.
High EFS, High Rate of Thrombosis With Crizotinib Plus Chemo in Pediatric ALCL
Crizotinib plus chemotherapy appears effective for pediatric patients with newly diagnosed ALCL, but the combination increases the risk of thrombosis.
CAR-T Therapy in Pediatric Leukemia: Past, Present, and Future
Prior to the introduction of CAR T-cell therapy, pediatric patients with ALL had limited treatment options for relapsed or refractory disease.
Hippocampal-Sparing Radiation May Be Feasible in Pediatric Medulloblastoma
Research suggests hippocampal-sparing radiation may be feasible for pediatric patients with medulloblastoma because the risk of peri‐hippocampal recurrence is low.
Tecentriq Approved for Unresectable or Metastatic Alveolar Soft Part Sarcoma
The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS.
FDA Rejects Omburtamab for Neuroblastoma After Disappointing Panel Vote
Omburtamab is an investigational radiolabeled monoclonal antibody designed to target tumor cells that express B7-H3.
Pediatric Cancer Survivors Experience Premature Aging
Young adult survivors of pediatric cancer experience significant premature aging, a retrospective study suggests.
FDA Approves Additional Dosing Schedule for Rylaze
The new dosing option was approved based on data from a phase 2/3 trial.
Neuroophthalmological Late Effects Common in Pediatric/Adolescent Medulloblastoma
Children and adolescents with medulloblastoma frequently suffer from neuroophthalmological sequelae, a single-center study suggests.
Data Show Similar Patterns of Relapse in Standard- and High-Risk Medulloblastoma
Patterns of relapse are similar in patients with standard-risk and high-risk medulloblastoma, a review suggests.
Tovorafenib Elicits Responses in Young Patients With BRAF-Altered Low-Grade Glioma
Tovorafenib produced responses in young patients with progressive or recurrent BRAF-altered low-grade glioma in a phase 2 trial.
Adcetris Approved for Pediatric Patients With High-Risk Classical Hodgkin Lymphoma
The approval was based on data from the open-label phase 3 AHOD1331 trial.
SAFER Ukraine: A Global Effort to Evacuate Children With Hematologic Cancers From Ukraine
The SAFER program is helping Ukrainian children with cancers and other blood disorders to continue their therapy in Ukraine or at centers in Europe and North America.
Chronic Conditions More Likely Among Survivors of Pediatric Wilms Tumor
Survivors of Wilms tumor are more likely than the general population to experience chronic health conditions, a study suggests.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...